Has Steven Ehrreich received payments from drug or device companies?

Yes. Drug and device makers reported $58,542 in general payments to Steven Ehrreich across 593 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Ehrreich did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Ehrreich come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Ehrreich

Pediatrics · Madera, CANPI 1780651893

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 51 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 54.9% of the total. 2025 is the largest year on record at $17,113, 4.1 times the $4,141 reported in 2019. Among pediatrics clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$58,542in general payments, 2019–2025

Across 593 payments — averaging $98.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Jazz Pharmaceuticals Inc.$32K
Catalyst Pharmaceuticals, Inc.$6K
Immedica Pharma US, Inc.$4K
Neuropace, Inc.$3K
Zogenix Inc.$2K
UCB, Inc.$2K
plus $9K from 45 others

What the payments were for

Consulting fees$6,02010%
Speaking & faculty fees$29,24250%
Travel & lodging$5,88310%
Food & beverage$17,39730%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Jazz Pharmaceuticals Inc.	76	$32,122
Catalyst Pharmaceuticals, Inc.	29	$6,179
Immedica Pharma US, Inc.	21	$4,056
Neuropace, Inc.	29	$3,421
Zogenix Inc.	11	$1,670
UCB, Inc.	62	$1,665
Livanova USA, Inc.	36	$1,228
Neurelis, Inc.	34	$1,068
Greenwich Biosciences, Inc.	26	$838
AstraZeneca(2 entities)	15	$561
Ipsen Biopharmaceuticals, Inc	16	$470
PTC Therapeutics, Inc.	25	$457
Eisai Inc.	26	$453
Supernus Pharmaceuticals, Inc.	16	$399
Aucta Pharmaceuticals, Inc.	14	$329
Biogen	13	$313
Sumitomo Pharma America, Inc.	18	$298
Novartis	14	$280
Acadia Pharmaceuticals Inc	8	$236
Sunovion Pharmaceuticals Inc.	18	$233
Biomarin Pharmaceutical Inc.	2	$206
Aquestive Therapeutics, Inc.	9	$189
Ironshore Pharmaceuticals Inc.	6	$166
SK Life Science, Inc.	6	$156
Monteris Medical Corporation	1	$137
Biocodex, Inc.	4	$125
Amneal Pharmaceuticals LLC	4	$109
Genentech USA, Inc.	4	$100
NS Pharma, Inc.	5	$99
ITF Therapeutics LLC	4	$84
Springworks Therapeutics, Inc.	4	$81
Argenx US, Inc.	3	$78
AbbVie(2 entities)	3	$76
Ceribell, Inc.	3	$71
Medtronic(2 entities)	2	$65
Upsher-smith Laboratories LLC	3	$64
Sanofi	3	$59
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)	3	$55
Ultragenyx Pharmaceutical Inc.	2	$39
Sarepta Therapeutics, Inc.	2	$37
Travere Therapeutics, Inc.	2	$36
Teva Pharmaceuticals USA, Inc.	2	$32
QOL Medical, LLC	1	$28
Azurity Pharmaceuticals, Inc.	1	$26
Mirum Pharmaceuticals, Inc.	1	$25
Nobelpharma America, LLC	1	$23
Kyowa Kirin, Inc.	1	$22
Johnson & Johnson	1	$22
Mallinckrodt Enterprises LLC	1	$20
Metacel Pharmaceuticals LLC	1	$19
Cranial Technologies, Inc	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Epidiolex$30,565
Fycompa$5,478
ZTALMY$3,831
Fintepla$1,646
RNS System$1,632
RNS Neurostimulator Kit$1,261
VNS Therapy$458
Palynziq$145
Neuroblate$137
QELBREE$125
VALTOCO$124
VNS THERAPY SENTIVA MODEL 1000 GENERATOR$109
Jornay PM 20mg capsules (Bottle of 100)$109

How this compares

$58,542 in reported general payments places this provider in the 95th percentile of 5,539 pediatrics providers in California.

See all pediatrics providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lamictal OdtLamotrigine	23	$20,743
KeppraLevetiracetam	11	$6,862
Clobazam	11	$1,146
Levetiracetam	14	$886
Lamotrigine	17	$555

Paid to pharmacies, not to this prescriber.

Other pediatrics in Madera

Laurene MascolaLos Angeles$451K
Tonya ChaffeeSan Francisco$359K
Anthony PortaleSan Francisco$354K
David KesslerSan Francisco$335K
Lawrence SherRolling Hills Estates$297K
Steven BlackOakland$228K
Jonathan StroberSan Francisco$164K
Hasmukh AminBakersfield$140K
Colleen KraftNewport Beach$122K
Lela BachrachOakland$119K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →